1. Home
  2. EXAS vs SQM Comparison

EXAS vs SQM Comparison

Compare EXAS & SQM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • EXAS
  • SQM
  • Stock Information
  • Founded
  • EXAS 1995
  • SQM 1968
  • Country
  • EXAS United States
  • SQM Chile
  • Employees
  • EXAS N/A
  • SQM N/A
  • Industry
  • EXAS Medical Specialities
  • SQM Mining & Quarrying of Nonmetallic Minerals (No Fuels)
  • Sector
  • EXAS Health Care
  • SQM Industrials
  • Exchange
  • EXAS Nasdaq
  • SQM Nasdaq
  • Market Cap
  • EXAS 10.5B
  • SQM 10.7B
  • IPO Year
  • EXAS N/A
  • SQM 1993
  • Fundamental
  • Price
  • EXAS $49.26
  • SQM $39.67
  • Analyst Decision
  • EXAS Strong Buy
  • SQM Hold
  • Analyst Count
  • EXAS 17
  • SQM 8
  • Target Price
  • EXAS $72.31
  • SQM $45.56
  • AVG Volume (30 Days)
  • EXAS 1.9M
  • SQM 847.5K
  • Earning Date
  • EXAS 02-19-2025
  • SQM 03-04-2025
  • Dividend Yield
  • EXAS N/A
  • SQM 0.54%
  • EPS Growth
  • EXAS N/A
  • SQM N/A
  • EPS
  • EXAS N/A
  • SQM N/A
  • Revenue
  • EXAS $2,758,867,000.00
  • SQM $4,766,643,000.00
  • Revenue This Year
  • EXAS $12.09
  • SQM N/A
  • Revenue Next Year
  • EXAS $11.24
  • SQM $20.61
  • P/E Ratio
  • EXAS N/A
  • SQM N/A
  • Revenue Growth
  • EXAS 10.37
  • SQM N/A
  • 52 Week Low
  • EXAS $40.62
  • SQM $32.24
  • 52 Week High
  • EXAS $79.62
  • SQM $51.90
  • Technical
  • Relative Strength Index (RSI)
  • EXAS 33.51
  • SQM 53.83
  • Support Level
  • EXAS $45.94
  • SQM $37.78
  • Resistance Level
  • EXAS $51.75
  • SQM $38.94
  • Average True Range (ATR)
  • EXAS 2.13
  • SQM 1.16
  • MACD
  • EXAS -0.30
  • SQM 0.07
  • Stochastic Oscillator
  • EXAS 32.20
  • SQM 74.68

About EXAS Exact Sciences Corporation

Exact Sciences, headquartered in Madison, Wisconsin, provides cancer screening and diagnostic test products in the United States and internationally. Exact's Cologuard screening test, a noninvasive stool-based DNA test, is a precancer screening test for colorectal cancer. The company also competes in the precision oncology market with Oncotype DX, a suite of tissue-based genomic tests for estimating recurrence risk and likelihood of benefit from chemotherapy for breast and colon cancer, and OncoExTra, a liquid-based comprehensive genomic profiling test. It is also developing liquid biopsy tests for molecular residual disease, colorectal cancer screening, and multicancer screening.

About SQM Sociedad Quimica y Minera S.A.

Sociedad Quimica y Minera de Chile is a Chilean commodities producer with significant operations in lithium (primarily used in batteries for electric vehicles and energy storage systems), specialty and standard potassium fertilizers, iodine (primarily used in X-ray contrast media), and solar salts. The company extracts these materials through its high-quality salt brine deposits and caliche ore. SQM is developing a hard rock lithium project in Australia and expanding its lithium refining assets in China.

Share on Social Networks: